Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
Clinical trial NCT03616860 · COMPLETED
Trial details
- NCT number
- NCT03616860
- Sponsor
- InSightec
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2023-12-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.